|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT02195258 |
|
Date of registration:
|
04/07/2013 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Pharmacogenetic of Salbutamol in Pediatric Asthma Crisis
Pegase |
|
Scientific title:
|
Pharmacogenetic of the Salbutamol Efficacy in Asthma Crisis for Children in Emergency Department |
|
Date of first enrolment:
|
November 2010 |
|
Target sample size:
|
95 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT02195258 |
|
Study type:
|
Observational [Patient Registry] |
|
Study design:
|
Observational Model: Case-Only, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
Hélène Chappuy, MDPhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
APHP |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- children
- 6-16 years old
- asthmatic patients
- consulting for an exacerbation in a pediatric emergency department
- parental informed consent
Exclusion Criteria:
- comorbidity
- peak flow no available
- pneumonia
Age minimum:
6 Years
Age maximum:
16 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Asthma
|
|
Primary Outcome(s)
|
|
pre- and post-bronchodilator FEV1 value (BDR = 100 x [post-FEV1 - pre-FEV1]/pre-FEV1)
[Time Frame: Day 0]
|
|
Secondary Outcome(s)
|
|
polymorphism on the response delay
[Time Frame: Day 0]
|
|
Secondary ID(s)
|
|
URC Paris centre
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|